Approval · Notice of Compliance 6519 · 1996
MERREM: Notice of Compliance 6519
Issued July 2, 1996
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 6519
- Date
- July 2, 1996
- Company
- Zeneca Pharma Inc.Mississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Antibiotic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MERREM | 02218488 | Cancelled Post Market |
| MERREM | 02218496 | Cancelled Post Market |
| MERREM (ADD-VANTAGE VIALS) | 02219026 | Cancelled Pre Market |
| MERREM (ADD-VANTAGE VIALS) | 02219018 | Cancelled Pre Market |